Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

CNTG
Centogene N.V. Common Shares
stock NASDAQ

Inactive
Aug 7, 2024
0.3250USD-6.232%(-0.0216)8,358,256
Pre-market
0.00USD-100.000%(-0.35)0
After-hours
0.00USD0.000%(0.00)0
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 20, 2022
06:30AM EST  -- CENTOGENE and Insilico Medicine will work together to identify, rank, and annotate proteins to identify novel therapeutic targets for NPC using AI -- NPC is a rare genetic disease occurring in approximately 1 in 120,000 live births, with many cases going mis- or undiagnosed -- There are currently no FDA-approved treatments for NPC   GlobeNewswire Inc
Jan 4, 2022
08:00AM EST  CENTOGENEs CentoCloud Set to   GlobeNewswire Inc
Dec 23, 2021
08:00AM EST  Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced that it has been awarded the Health-i Award, which recognizes companies that are transforming healthcare in Germany and beyond.   GlobeNewswire Inc
Dec 20, 2021
08:35AM EST  CENTOGENE Announces CEO To Take Temporary Medical Leave Of Absence; Kim Stratton Appointed As Interim CEO   Benzinga
08:30AM EST  Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, announced today that its Chief Executive Officer, Andrin Oswald, M.D., is taking a temporary medical leave of absence for a period of at least four weeks.   GlobeNewswire Inc
Nov 24, 2021
07:37AM EST  Centogene Reports Q3 Sales 30.2M Down From   Benzinga
07:36AM EST  Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced financial results for the third quarter ended September 30, 2021, and provided a recent business update.   GlobeNewswire Inc
07:32AM EST  The Daily Biotech Pulse: Kura's Blood Cancer Drug Study Gets Partial Clinical Hold, Takeda FDA Nod, Puma Breast Cancer Treatment Gets Patent Extension   Benzinga
03:35AM EST  Earnings Scheduled For November 24, 2021   Benzinga
Nov 23, 2021
10:40AM EST  Earnings Preview For Centogene   Benzinga
Nov 21, 2021
03:05PM EST  The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week   Benzinga
Nov 18, 2021
06:30AM EST  CENTOGENE to Announce Third Quarter 2021 Financial Results on   GlobeNewswire Inc
Nov 4, 2021
06:39AM EDT  CENTOGENE To Provide Genetic Testing And Clinical Trial Support For Agios' Three Global, Pivotal Trials In Thalassemia And Sickle Cell Disease   Benzinga
06:30AM EDT  CENTOGENE Expands Partnership With Agios to Generate Novel   GlobeNewswire Inc
Oct 28, 2021
06:30AM EDT  -- FTD is a rapidly progressing neurodegenerative disease; up to 30% of all cases worldwide caused by genetic mutations, including the progranulin gene mutation (FTD-GRN) -- Study will enroll and genetically test over 3,000 FTD patients at multiple sites in seven countries -- There are currently no FDA-approved treatments for FTD   GlobeNewswire Inc
Oct 6, 2021
03:50PM EDT  Centogene, Twist Join Forces For Custom Test Kits For Rare Diseases   Benzinga
08:06AM EDT  Centogene, Twist Bioscience Report Contract To Collab On Development, Commercialization Of Custom Assay Kits For Rare Diseases, No Terms Disclosed   Benzinga
08:00AM EDT  CENTOGENE and Twist Bioscience to Develop Advanced Sequencing   GlobeNewswire Inc
Sep 30, 2021
07:43AM EDT  The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug   Benzinga
Sep 29, 2021
05:05PM EDT  CENTOGENEs Ground-Breaking Family Genetic   GlobeNewswire Inc
Sep 7, 2021
06:55AM EDT  Centogene Q2 Revenues EUR 51.9 Mln, Up From EUR 9.7 Mln Last Year   RTTNews
06:36AM EDT  Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced financial results for the second quarter ended June 30, 2021, and provided an update on recent business progress.   GlobeNewswire Inc
06:29AM EDT  Centogene Q2 Revenues 51.9M, Up 434% YoY; Commercial OVID-19 Testing Revenues 42.3M, Up From 2.1M YoY   Benzinga
04:00AM EDT  Earnings Scheduled For September 7, 2021   Benzinga
Sep 5, 2021
01:14PM EDT  The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week   Benzinga
Sep 1, 2021
06:30AM EDT  Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced that it will issue its financial results for the quarter ended June 30, 2021, on Tuesday, September 7, 2021, and will host a conference call and webcast to discuss these results at 2 p.m. CEST / 8 a.m. EDT that day.   GlobeNewswire Inc
Jul 27, 2021
11:13AM EDT  The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts   Benzinga
06:30AM EDT  Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced the appointment of Dr. Patrice P. Denfle as Chief Scientific Officer (CSO). Dr. Denfle will join CENTOGENE on August 16, 2021, succeeding Phil Lambert, who has decided to leave the Company.   GlobeNewswire Inc
Jun 25, 2021
06:34AM EDT  CENTOGENE Reports Shareholders Approve All Resolutions From Annual General Meeting   Benzinga
06:30AM EDT  CENTOGENE Announces Shareholders Approve All Resolutions at Annual   GlobeNewswire Inc
Jun 22, 2021
06:41AM EDT  CENTOGENE Says Confident About Its Path To Enabling Cure Of 100 Rare Diseases   RTTNews
06:32AM EDT  CENTOGENE Announces Investor Event Jun. 22 At 9:00 a.m. EDT   Benzinga
06:30AM EDT  CENTOGENE Sets Mission to Enable the Cure of 100 Rare Diseases   GlobeNewswire Inc
Jun 17, 2021
07:46AM EDT  Credit Suisse Maintains Outperform on Centogene, Lowers Price Target to $14   Benzinga
Jun 16, 2021
08:20AM EDT  The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO   Benzinga
06:47AM EDT  Centogene Q1 Revenues EUR 65.0 Mln Vs EUR 12.1 Mln Last Year   RTTNews
06:40AM EDT  Centogene Q1 Sales 65M, Up 400% YoY   Benzinga
06:30AM EDT  CENTOGENE Reports First Quarter 2021 Financial Results in the Lead   GlobeNewswire Inc
04:03AM EDT  Earnings Scheduled For June 16, 2021   Benzinga
Jun 9, 2021
04:30PM EDT  Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced that it will issue its financial results for the quarter ended March 31, 2021, on Wednesday, June 16, 2021.   GlobeNewswire Inc
Jun 7, 2021
06:30AM EDT  Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, announced today that it will be holding a Virtual Investor Event on Tuesday, June 22, 2021, at 9:00 a.m. - 11:00 a.m. EDT / 3:00 p.m. - 5:00 p.m. CEST.   GlobeNewswire Inc
Jun 2, 2021
06:39AM EDT  Centogene Announce Observational Study To Understand Prevalence Of Genetic Mutations In FTD Patients   RTTNews
06:34AM EDT  CENTOGENE Initiates EFRONT Study To Identify Patients With Genetic Forms Of Frontotemporal Dementia; Study Being Conducted With Support From Alector   Benzinga
06:31AM EDT  CENTOGENE Initiates EFRONT Study to Identify Patients With Genetic   GlobeNewswire Inc
Jun 1, 2021
06:30AM EDT  CENTOGENE Launches NEW CentoXome - An Enhanced Whole   GlobeNewswire Inc
May 26, 2021
06:34AM EDT  Centogene Announces Nomination Of Rene Just As CFO   RTTNews
06:30AM EDT  CENTOGENE Announces the Nomination of Rene Just as Chief Financial   GlobeNewswire Inc
May 18, 2021
06:41AM EDT  Centogene Appoints Michael Motz As Chief Commercial Officer, Pharmaceuticals   RTTNews
06:30AM EDT  Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, today announced the appointment of Dr. Michael Motz as Chief Commercial Officer, Pharmaceuticals, who will join the company on June 1, 2021.   GlobeNewswire Inc
May 12, 2021
08:57AM EDT  The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron   Benzinga
May 11, 2021
07:54AM EDT  The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings   Benzinga
May 10, 2021
06:40AM EDT  CENTOGENE Extends Rostock International Parkinson's Disease Study   RTTNews
06:30AM EDT  Providing patients with genetic testing designed to accelerate the diagnosis and personalized treatment of Parkinsons disease (PD)   GlobeNewswire Inc
May 6, 2021
06:30AM EDT  New CentoMD 6.0 Update Brings Deeper Insights Into   GlobeNewswire Inc
May 5, 2021
06:30AM EDT  CENTOGENE Discovers Six New Rare Diseases by Leveraging the   GlobeNewswire Inc
Apr 15, 2021
07:49AM EDT  The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split   Benzinga
06:41AM EDT  Centogene Reports Revenues More Than Doubled In 2020 Compared To 2019 For A Record 128.4M   Benzinga
06:30AM EDT  CENTOGENE Reports Record Fourth Quarter and Full Year 2020   GlobeNewswire Inc
04:13AM EDT  Earnings Scheduled For April 15, 2021   Benzinga
Apr 14, 2021
06:32AM EDT  Centogene Reports Extension Of Partnership With Takeda Pharma To Diagnose Patients With Certain Genetic Disorders, Extends Til Mar. 2022   Benzinga
06:30AM EDT  CENTOGENE Extends Partnership With Takeda   GlobeNewswire Inc
Apr 10, 2021
09:19AM EDT  The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight   Benzinga
Apr 8, 2021
06:30AM EDT  CENTOGENE to Announce Full Year 2020 Financial Results on April   GlobeNewswire Inc
Mar 9, 2021
09:15AM EST  CENTOGENE Reaches 10,000 Participants In Global Parkinson's Disease Study   Benzinga
06:30AM EST  CENTOGENE Reaches 10,000 Participant Milestone in Global   GlobeNewswire Inc
Dec 18, 2020
10:02AM EST  CENTOGENE Announces Voting Results of Extraordinary General Meeting   GlobeNewswire Inc
Dec 16, 2020
07:15AM EST  The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal   Benzinga
07:03AM EST  Recap: Centogene Q3 Earnings   Benzinga
06:43AM EST  CENTOGENE Q3 Revenue EUR 36.305 Mln Vs EUR 11.638 Mln Last Year   RTTNews
06:30AM EST  CENTOGENE Reports Third-Quarter 2020 Financial Results and   GlobeNewswire Inc
04:21AM EST  Earnings Scheduled For December 16, 2020   Benzinga
Dec 13, 2020
04:27PM EST  The Week Ahead In Biotech: 2 IPOs Plus FDA Decisions On Moderna's COVID Vaccine And Drugs From Amgen, MacroGenics   Benzinga
Dec 9, 2020
06:30AM EST  CENTOGENE to Report Third-Quarter 2020 Financial Results on   GlobeNewswire Inc
Dec 8, 2020
06:30AM EST  CENTOGENE and Alnylam Pharmaceuticals Launch a New Clinical   GlobeNewswire Inc
Nov 26, 2020
02:46AM EST  Centogene Says Its Antigen Tests Now Available At Frankfurt Airport   RTTNews
Nov 25, 2020
06:33AM EST  CENTOGENE Expands Partnership With PTC Therapeutics To 'Generate New Insights for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency'   Benzinga
06:30AM EST  CENTOGENE Expands Partnership with PTC Therapeutics to Generate   GlobeNewswire Inc
Nov 13, 2020
11:30AM EST  CENTOGENE Announces Nomination of Jonathan Sheldon to Supervisory   GlobeNewswire Inc
Nov 9, 2020
04:00AM EST  Fujirebio Europe and CENTOGENE Enter Partnership to Provide Rapid   GlobeNewswire Inc
Nov 5, 2020
10:28AM EST  Benzinga's Top Upgrades, Downgrades For November 5, 2020   Benzinga
07:58AM EST  Credit Suisse Initiates Coverage On Centogene with Outperform Rating, Announces Price Target of $15   Benzinga
02:00AM EST  CENTOGENE Opens Walk-In COVID-19 Testing Facility at Berlin   GlobeNewswire Inc
Oct 20, 2020
08:17AM EDT  The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout, Cara Executes Korsuva Licensing Deal, Cleveland BioLabs Rallies On Reverse Merger   Benzinga
06:03AM EDT  CENTOGENE Announces CEO Transition   Benzinga
06:00AM EDT  CENTOGENE Announces Leadership Transition   GlobeNewswire Inc
05:30AM EDT  CENTOGENE Increases Full-Year 2020 Guidance   GlobeNewswire Inc
Oct 19, 2020
10:19AM EDT  Shares of Centogene N.V. (CNTG) are rising more than 11% Monday morning after the company said it has received Emergency Use Authorization (EUA) from the FDA for 'CentoSure', the company's latest SARS-CoV-2 RT-PCR test.   RTTNews
06:48AM EDT  Centogene N.V. (CNTG) said the FDA has issued Emergency Use Authorization for CentoSure, the company's SARS-CoV-2 RT-PCR test. CentoSure SARS-CoV-2 RT-PCR assay is a real-time test based on the reverse transcription polymerase chain reaction for the qualitative detection of SARS-CoV-2, the virus causing COVID-19.   RTTNews
06:38AM EDT  CENTOGENE Receives FDA Emergency Use Authorization For SARS-CoV-2 RT-PCR Assay   RTTNews
06:31AM EDT  CENTOGENE Receives FDA Emergency Use Authorization for SARS-CoV-2 RT-PCR Assay for Individuals Without Symptoms or Other Reasons to Suspect COVID-19   Benzinga
06:30AM EDT  CENTOGENE Receives FDA Emergency Use Authorization for SARS-CoV-2   GlobeNewswire Inc
Oct 14, 2020
08:14AM EDT  Collaboration Between CENTOGENE and U-Diagnostics Increases   GlobeNewswire Inc
Oct 7, 2020
10:09AM EDT  Benzinga's Top Upgrades, Downgrades For October 7, 2020   Benzinga
06:34AM EDT  Kempen & Co Initiates Coverage On Centogene with Buy Rating, Announces Price Target of $22   Benzinga
Sep 28, 2020
06:30AM EDT  CENTOGENEs Information Security Management   GlobeNewswire Inc
Sep 23, 2020
09:45AM EDT  Centogene shares are trading higher after the company announced it has opened a walk-in COVID-19 testing facility at the Dsseldorf airport.   Benzinga
07:50AM EDT  Centogene N.V. (Nasdaq: CNTG) (CENTOGENE or the Company), a commercial-stage company focused on rare diseases that transforms real- world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, today provided an update on its corporate progress and reported its financial results for the three and six months ended June 30, 2020.   GlobeNewswire Inc
06:26AM EDT  CENTOGENE Opened Walk-In COVID-19 Testing Facility at Dsseldorf Airport   Benzinga
04:04AM EDT  Earnings Scheduled For September 23, 2020   Benzinga
03:30AM EDT  CENTOGENE Opens Walk-In COVID-19 Testing Facility at   GlobeNewswire Inc
Sep 16, 2020
08:30AM EDT  CENTOGENE to Report First Half 2020 Financial Results on September   GlobeNewswire Inc
Sep 10, 2020
08:24AM EDT  CENTOGENE Expands Coronavirus Testing Capacity At Frankfurt Airport   Benzinga
Sep 3, 2020
06:30AM EDT  -- Publication demonstrates genome sequencing as the optimal standard for genetic testing -- Study presents the largest cohort of its kind with over 1,000 index cases -- Genome sequencing minimizes stepwise testing, thereby accelerating diagnosis for rare disease patients   GlobeNewswire Inc
Sep 1, 2020
08:30AM EDT  CENTOGENEs COVID-19 Testing Numbers Represent   GlobeNewswire Inc
Aug 20, 2020
06:13AM EDT  CENTOGENE and Evotec Announced Expanded Collaboration Into Gaucher Disease   Benzinga
01:48AM EDT  Evotec, CENTOGENE Expand Partnership With Focus On Gaucher   RTTNews
01:32AM EDT  Evotec, CENTOGENE Expand Existing Drug Discovery Partnership   RTTNews
01:30AM EDT  CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease   GlobeNewswire Inc
Aug 19, 2020
05:34AM EDT  CENTOGENE Opens Walk-In COVID-19 Testing Facility at Hamburg Airport   Benzinga
Aug 11, 2020
06:30AM EDT  CentoMD Update Reveals Further Insights Into Rare Diseases   GlobeNewswire Inc
Aug 4, 2020
06:30AM EDT  CENTOGENE Supports Tajikistan in Fight Against the COVID-19 Pandemic   GlobeNewswire Inc
Jul 27, 2020
08:15AM EDT  CENTOGENE and Molecular Health Announce Exclusive Collaboration With The 'Aim to Transform the Development of Orphan Drugs'   Benzinga
08:14AM EDT  Centogene, Molecular Health Collaborate To Transform Development Of Orphan Drugs   RTTNews
08:01AM EDT  CENTOGENE and Molecular Health Announce an Exclusive Collaboration   GlobeNewswire Inc
Jul 23, 2020
10:35AM EDT  Shares of commercial-stage rare disease company Centogene N.V. (CNTG) are rising more than 11% Thursday morning at $13.35. It has been trading in the range of $7.80- $28.71 in the past 52-weeks.   RTTNews
05:37AM EDT  CENTOGENE Announces At-Home Coronavirus Test Solution Now Available in Germany on Amazon.de   Benzinga
02:30AM EDT  CENTOGENE Announces Convenient At-Home Coronavirus Test Solution   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC